UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

Neuro-oncology (Charlottesville, Va.), 2008-06, Vol.10 (3), p.320-329

2008

Volltextzugriff (PDF)

Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results

Journal of clinical oncology, 2006-01, Vol.24 (1), p.115-122

2006

Volltextzugriff (PDF)

Functional genomics screening utilizing mutant mouse embryonic stem cells identifies novel radiation-response genes

PloS one, 2015-04, Vol.10 (4), p.e0120534-e0120534

2015

Volltextzugriff (PDF)

Production of 99Mo/99mTc via photoneutron reaction using natural molybdenum and enriched 100Mo: part 1, theoretical analysis

Journal of radioanalytical and nuclear chemistry, 2017, Vol.314 (2), p.1051-1062

2017

Volltextzugriff (PDF)

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3862-3872

2000

Volltextzugriff (PDF)

Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity

Journal of the American Chemical Society, 2018-01, Vol.140 (4), p.1438-1446

2018

Volltextzugriff (PDF)

Clinical Experience with α-Particle–Emitting 211 At: Treatment of Recurrent Brain Tumor Patients with 211 At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

Journal of Nuclear Medicine, 2008-01, Vol.49 (1), p.30-38

2008

Volltextzugriff (PDF)

Radioimmunotherapy for Non-Hodgkin’s Lymphoma

Clinical medicine & research, 2005-08, Vol.3 (3), p.157-165

2005

Volltextzugriff (PDF)

Control of seizures by ketogenic diet-induced modulation of metabolic pathways

Amino Acids, 2017, Vol.49 (1), p.1-20

2017

Volltextzugriff (PDF)

MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy

Journal of Nuclear Medicine, 2010-02, Vol.51 (2), p.311-328

2010

Volltextzugriff (PDF)

Rapid synthesis of 125I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

Applied radiation and isotopes, 2018-01, Vol.131 (C)

2018

Volltextzugriff (PDF)

Rapid synthesis of 125I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

Applied radiation and isotopes, 2018-01, Vol.131 (C), p.49-57

2018

Volltextzugriff (PDF)

A STUDY OF A DOSE CONSTRAINT FOR OCCUPATIONALLY EXPOSED WORKERS IN THE US NUCLEAR POWER PLANTS

Radiation protection dosimetry, 2019-06, Vol.183 (4), p.502-513

2019

Volltextzugriff (PDF)

Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy

International journal of radiation oncology, biology, physics, 2021-03, Vol.109 (4), p.905-912

2021

Volltextzugriff (PDF)

A Novel Method to Extend a Partial-Body CT for the Reconstruction of Dose to Organs beyond the Scan Range

Radiation research, 2018-06, Vol.189 (6), p.618-626

2018

Volltextzugriff (PDF)

A Study of a Dose Constraint for Members of the Public Living Around Nuclear Power Plants in the United States

Nuclear technology, 2019-06, Vol.205 (6), p.781-789

2019

Volltextzugriff (PDF)

Overview of the First NRG Oncology-National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy

Journal of Nuclear Medicine, 2021-08, Vol.62 (8), p.1133-1139

2021

Volltextzugriff (PDF)

A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

Neuro-oncology (Charlottesville, Va.), 2008-04, Vol.10 (2), p.182-189

2008

Volltextzugriff (PDF)

Rapid synthesis of 125 I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

Applied radiation and isotopes, 2018-01, Vol.131, p.49

2018

Volltextzugriff (PDF)

Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature

Environmental research, 2015-10, Vol.142, p.239-256

2015

Volltextzugriff (PDF)

A dose constraint proposal for members of the public taking into account multi-unit nuclear power plants in Korea

Journal of nuclear science and technology, 2015-05, Vol.52 (5), p.739-747

2015

Volltextzugriff (PDF)

Migration of human dendritic cells after injection in patients with metastatic malignancies

Cancer research (Chicago, Ill.), 1999, Vol.59 (1), p.56-58

1999

Volltextzugriff (PDF)

Radiological safety concerns for the accelerator production of diagnostic and therapeutic radionuclides in a university setting

Health physics (1958), 2012-11, Vol.103 (5 Suppl 3), p.S209-S216

2012

Volltextzugriff (PDF)

THE SPARSITY-PROMOTED SOLUTION TO THE UNDERSAMPLING TOF-PET IMAGING: NUMERICAL SIMULATIONS

Electromagnetic waves (Cambridge, Mass.), 2013-01, Vol.133, p.235-258

2013

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(84)

Erscheinungsjahr

n.n

Thema

Humans
(41)
Science & Technology
(38)
Life Sciences & Biomedicine
(32)
Radiology, Nuclear Medicine & Medical Imaging
(24)
Biological And Medical Sciences
(23)
Medical Sciences
(22)
Male
(21)
Female
(19)
Middle Aged
(17)
Adult
(15)
Animals
(14)
Radioimmunotherapy
(13)
Mice
(12)
Tenascin - Immunology
(12)
Antibodies, Monoclonal - Therapeutic Use
(11)
Aged
(10)
Brain Neoplasms - Radiotherapy
(10)
Oncology
(10)
Glioma - Radiotherapy
(9)
Iodine Radioisotopes - Therapeutic Use
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results

Functional genomics screening utilizing mutant mouse embryonic stem cells identifies novel radiation-response genes

Production of 99Mo/99mTc via photoneutron reaction using natural molybdenum and enriched 100Mo: part 1, theoretical analysis

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity

Clinical Experience with α-Particle–Emitting 211 At: Treatment of Recurrent Brain Tumor Patients with 211 At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

Radioimmunotherapy for Non-Hodgkin’s Lymphoma

Control of seizures by ketogenic diet-induced modulation of metabolic pathways

MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy

Rapid synthesis of 125I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

Rapid synthesis of 125I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

A STUDY OF A DOSE CONSTRAINT FOR OCCUPATIONALLY EXPOSED WORKERS IN THE US NUCLEAR POWER PLANTS

Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy

A Novel Method to Extend a Partial-Body CT for the Reconstruction of Dose to Organs beyond the Scan Range

A Study of a Dose Constraint for Members of the Public Living Around Nuclear Power Plants in the United States

Overview of the First NRG Oncology-National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy

A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

Rapid synthesis of 125 I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature

A dose constraint proposal for members of the public taking into account multi-unit nuclear power plants in Korea

Migration of human dendritic cells after injection in patients with metastatic malignancies

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors

Radiological safety concerns for the accelerator production of diagnostic and therapeutic radionuclides in a university setting

THE SPARSITY-PROMOTED SOLUTION TO THE UNDERSAMPLING TOF-PET IMAGING: NUMERICAL SIMULATIONS

Suchergebnisse filtern